Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$339M |
| 3 |
Tesla
TSLA
|
+$275M |
| 4 |
Alibaba
BABA
|
+$236M |
| 5 |
AGN
Allergan plc
AGN
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$474M |
| 2 |
Gilead Sciences
GILD
|
+$359M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
Intel
INTC
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.94% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.42% |
| 4 | Communication Services | 1.04% |
| 5 | Healthcare | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
PUT
Wabtec
WAB
$49.4B
| $1.54M | ﹤0.01% |
20,300
+10,700
| +111% | +$824K |
|
4377
CALL
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.9B
| $1.54M | ﹤0.01% |
12,400
+3,400
| +38% | +$402K |
|
4378
iShares Global Consumer Discretionary ETF
RXI
$270M
| $1.54M | ﹤0.01% |
15,092
-29,606
| -66% | -$2.97M |
|
4379
Novavax
NVAX
$1.53B
| $1.54M | ﹤0.01% |
67,389
+25,491
| +61% | +$571K |
|
4380
Valmont Industries
VMI
$9.19B
| $1.54M | ﹤0.01% |
+9,714
| New | +$1.46M |
|
4381
VanEck Steel ETF
SLX
$177M
| $1.53M | ﹤0.01% |
36,369
-2,622
| -7% | -$109K |
|
|
CIM
4382
CALL
Chimera Investment
CIM
$963M
| $1.53M | ﹤0.01% |
27,033
-1,100
| -4% | -$62.4K |
|
4383
Axalta
AXTA
$7.92B
| $1.53M | ﹤0.01% |
+52,998
| New | +$1.6M |
|
4384
TriMas Corp
TRS
$1.42B
| $1.53M | ﹤0.01% |
56,751
-46,708
| -45% | -$1.12M |
|
4385
ATI
ATI
$28.7B
| $1.53M | ﹤0.01% |
63,996
+6,125
| +11% | +$121K |
|
4386
CALL
Integra LifeSciences
IART
$1.31B
| $1.53M | ﹤0.01% |
30,300
+21,200
| +233% | +$1.09M |
|
|
DISCK
4387
CALL
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.53M | ﹤0.01% |
75,500
+36,400
| +93% | +$817K |
|
4388
PUT
VanEck Biotech ETF
BBH
$460M
| $1.53M | ﹤0.01% |
11,400
+1,900
| +20% | +$247K |
|
4389
CALL
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.6B
| $1.53M | ﹤0.01% |
73,000
-85,000
| -54% | -$1.75M |
|
4390
CALL
Ziff Davis
ZD
$1.91B
| $1.53M | ﹤0.01% |
23,805
+5,865
| +33% | +$397K |
|
4391
CALL
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.2B
| $1.53M | ﹤0.01% |
30,600
+2,500
| +9% | +$122K |
|
|
GTT
4392
DELISTED
GTT Communications, Inc.
GTT
| $1.53M | ﹤0.01% |
48,242
-26,105
| -35% | -$797K |
|
4393
Builders FirstSource
BLDR
$7.29B
| $1.53M | ﹤0.01% |
84,801
-51,183
| -38% | -$825K |
|
|
LQ
4394
DELISTED
La Quinta Holdings Inc.
LQ
| $1.53M | ﹤0.01% |
87,208
-112,875
| -56% | -$1.75M |
|
|
CLLS
4395
CALL
Cellectis
CLLS
$342M
| $1.52M | ﹤0.01% |
+53,600
| New | +$1.39M |
|
4396
Invesco Semiconductors ETF
PSI
$2.35B
| $1.52M | ﹤0.01% |
92,589
+31,440
| +51% | +$473K |
|
|
TSE
4397
CALL
DELISTED
Trinseo
TSE
| $1.52M | ﹤0.01% |
22,700
+5,800
| +34% | +$386K |
|
|
DOC
4398
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $1.52M | ﹤0.01% |
85,800
-428,978
| -83% | -$7.92M |
|
|
SWIR
4399
PUT
DELISTED
Sierra Wireless
SWIR
| $1.52M | ﹤0.01% |
70,700
+46,200
| +189% | +$1.14M |
|
|
ZEN
4400
PUT
DELISTED
ZENDESK INC
ZEN
| $1.52M | ﹤0.01% |
52,200
-80,600
| -61% | -$2.26M |
|
Similar funds
Jeff Yass's Q3 2017 Portfolio in Review
As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2017 filing shows 1,312 new, 3,605 increased, 3,645 reduced and 1,693 closed positions. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $474M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
- Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
- Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
- Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
- Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
- Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
- Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.
Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.